Docoh
Loading...

18 results

Filter options loading...
Top filers
Top filing types
Recent filing years
10-K
2020 FY
PCSA Processa Pharmaceuticals Inc
24 Mar 21
Annual report
8:00pm
of our company, you may not recoup all or any portion of your investment. In the event of a liquidation, dissolution or winding-up of our operations
424B4
PCSA Processa Pharmaceuticals Inc
5 Oct 20
Prospectus supplement with pricing info
4:16pm
be dissolution of our company, you may not recoup all or any portion of your investment. In the event of a liquidation, dissolution or winding-up of our
S-1/A
PCSA Processa Pharmaceuticals Inc
30 Sep 20
IPO registration (amended)
4:06pm
. If there should be dissolution of our company, you may not recoup all or any portion of your investment. In the event of a liquidation, dissolution
S-1/A
PCSA Processa Pharmaceuticals Inc
16 Sep 20
IPO registration (amended)
8:00pm
company, you may not recoup all or any portion of your investment. In the event of a liquidation, dissolution or winding-up of our operations
S-1/A
PCSA Processa Pharmaceuticals Inc
17 Jul 20
IPO registration (amended)
5:25pm
stockholders and could adversely affect the market price, if any, of our common stock. If there should be dissolution of our company, you may not recoup
10-K
2019 FY
PCSA Processa Pharmaceuticals Inc
5 Mar 20
Annual report
7:00pm
company, you may not recoup all or any portion of your investment. In the event of a liquidation, dissolution or winding-up of our operations, whether
S-1
PCSA Processa Pharmaceuticals Inc
13 Dec 19
IPO registration
5:32pm
not recoup all or any portion of your investment. In the event of a liquidation, dissolution or winding-up of our operations, whether voluntary
10-K/A
2018 FY
PCSA Processa Pharmaceuticals Inc
5 Apr 19
Annual report (amended)
9:40pm
stock. If there should be dissolution of our company, you may not recoup all or any portion of your investment. In the event of a liquidation
10-K
2018 FY
PCSA Processa Pharmaceuticals Inc
28 Mar 19
Annual report
5:25pm
stock. If there should be dissolution of our company, you may not recoup all or any portion of your investment. In the event of a liquidation
424B3
PCSA Processa Pharmaceuticals Inc
9 Nov 18
Prospectus supplement
5:04pm
not recoup all or any portion of your investment. In the event of a liquidation, dissolution or winding-up of our Company, whether voluntary or involuntary
S-1/A
PCSA Processa Pharmaceuticals Inc
30 Oct 18
IPO registration (amended)
4:19pm
be dissolution of our company, you may not recoup all or any portion of your investment. In the event of a liquidation, dissolution or winding-up of our
S-1/A
PCSA Processa Pharmaceuticals Inc
9 Oct 18
IPO registration (amended)
5:32pm
adversely affect the market price, if any, of our common stock. If there should be dissolution of our company, you may not recoup all or any portion
S-1/A
PCSA Processa Pharmaceuticals Inc
13 Sep 18
IPO registration (amended)
8:00pm
, if any, of our common stock. If there should be dissolution of our company, you may not recoup all or any portion of your investment. In the event
S-1
PCSA Processa Pharmaceuticals Inc
29 Jul 18
IPO registration
8:00pm
. If there should be dissolution of our company, you may not recoup all or any portion of your investment. In the event of a liquidation, dissolution
10-K/A
2017 FY
PCSA Processa Pharmaceuticals Inc
16 Apr 18
Annual report (amended)
8:00pm
purchased their shares. If there should be dissolution of our company, you may not recoup all or any portion of your investment. In the event … to recoup. Insofar as indemnification by us for liabilities arising under the Securities Exchange Act may be permitted to our directors, officers
10-K
2017 FY
PCSA Processa Pharmaceuticals Inc
15 Apr 18
Annual report
8:00pm
be dissolution of our company, you may not recoup all or any portion of your investment. In the event of a liquidation, dissolution or winding-up of our … expense or other matter. This indemnification policy could result in substantial expenditure by us, which we may be unable to recoup. Insofar
8-K/A
PCSA Processa Pharmaceuticals Inc
16 Oct 17
Entry into a Material Definitive Agreement
8:00pm
and political and legal actions in the future. Adverse pricing limitations may hinder our ability to recoup our investment in one or more future product … expenditure by us, which we may be unable to recoup. Insofar as indemnification by us for liabilities arising under the Securities Exchange Act may
8-K
PCSA Processa Pharmaceuticals Inc
11 Oct 17
Entry into a Material Definitive Agreement
8:00pm
greater regulation and political and legal actions in the future. Adverse pricing limitations may hinder our ability to recoup our investment in one … to recoup. Insofar as indemnification by us for liabilities arising under the Securities Exchange Act may be permitted to our directors, officers
  • 1